KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS

被引：0
|
作者：
LUSHER, J
ARKIN, S
ABILDGAARD, CF
HURST, D
机构：
[1] WASHINGTON STATE UNIV,KOGENATE PUP STUDY GRP,PULLMAN,WA 99164
[2] MILES INC,BERKELEY,CA
[3] CUNY MT SINAI SCH MED,NEW YORK,NY 10029
[4] UNIV CALIF DAVIS,DAVIS,CA 95616
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A239 / A239
页数：1
相关论文
共 50 条
  • [21] A safety and efficacy evaluation of rFIX in previously untreated patients (PUPS) with severe and moderately severe hemophilia B
    Shapiro, A
    Pasi, KJ
    Courter, S
    Tubridy, K
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS212 - PS212
  • [22] Risk of bleeding and inhibitor development after circumcision of Previously Untreated (PUPs) or Minimally Treated (MTPs) severe hemophilia A patients
    Elalfy, M.
    Elbarbary, N.
    Eldebeiky, M.
    El Danasoury, A.
    HAEMOPHILIA, 2012, 18 : 89 - 89
  • [23] CD4 COUNTS IN HIV-NEGATIVE PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A RECEIVING RFVIII (KOGENATE)
    WARRIER, I
    LUSHER, J
    ARKIN, S
    ABILDGAARD, C
    TENGBORN, L
    HUTHKUEHNE, A
    HURST, D
    TRANSFUSION, 1994, 34 (08) : 732 - 733
  • [24] Low inhibitor incidence in previously untreated hemophilia A patients (PUPs) treated with Octanate®
    Klukowska, A.
    Laguna, P.
    Komrska, V.
    Jansen, M.
    HAEMOPHILIA, 2010, 16 : 37 - 37
  • [25] INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATMENT PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE
    LUSHER, JM
    ARKIN, S
    ABILDGAARD, CF
    INWOOD, M
    ZIMMERMANN, R
    HILGARTNER, M
    HURST, D
    BLOOD, 1993, 82 (10) : A153 - A153
  • [26] Final results of the PUPs B-LONG study: evaluating safety and efficacy of rFIXFc in previously untreated patients with hemophilia B
    Nolan, Beatrice
    Klukowska, Anna
    Shapiro, Amy
    Rauch, Antoine
    Recht, Michael
    Ragni, Margaret
    Curtin, Julie
    Gunawardena, Sriya
    Mukhopadhyay, Sutirtha
    Jayawardene, Deepthi
    Winding, Bent
    Fischer, Kathelijn
    Liesner, Raina
    BLOOD ADVANCES, 2021, 5 (13) : 2732 - 2739
  • [27] Inhibitor development in previously untreated patients (PUPs) with hemophilia A and B: A prospective 23-year-follow-up
    Ettingshausen, CE
    Zyschka, A
    Oldenburg, J
    Saguer, IM
    Ehrenforth, S
    Kreuz, W
    Goethe, JW
    THROMBOSIS AND HAEMOSTASIS, 1999, : 410 - 410
  • [28] EFFICACY AND SAFETY OF PROPHYLAXIS IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A IN IRAN
    Karimi, M.
    Eshghi, P.
    Haghpanah, S.
    Zahedi, Z.
    Habibpanah, B.
    HAEMATOLOGICA, 2015, 100 : 409 - 409
  • [29] Inhibitor incidence in previously untreated patients (PUPs) with severe hemophilia A receiving recombinant factor (rFVIII)
    Rothschild, C
    Laurian, Y
    Satre, EP
    BorelDerlon, A
    Chambost, H
    Moreau, P
    Goudemand, J
    Parquet, A
    Vicariot, M
    Beurrier, P
    Claeyssens, S
    Durin, A
    Faradji, A
    Fressinaud, E
    Gaillard, S
    Guerin, V
    Guerois, C
    Pernod, G
    Peynet, J
    Pouzol, P
    Schved, JF
    Gazengel, C
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2654 - P2654
  • [30] Safety and efficacy of pasteurized, immunoaffinity purified factor VIII:C (Monoclate P®) in previously untreated hemophilia-A patients.
    Philipp, CS
    BLOOD, 1998, 92 (10) : 50A - 50A
12345